With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

NeoGenomics will present new data at ASH on how comprehensive genomic profiling supports diagnosis and treatment decisions in ...

Captain (scores 1.5x fantasy points): Prescott ($15,600) has thrown for 320 or more yards in each of his last two games, with ...

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Comparing proteomics to genomics reveals essential insights into their contributions to systems biology and experimental ...

Arima Genomics, Inc ., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced new data to be presented at the ...

Ziosoft, a pioneer in advanced visualization (AV) and leader in robust AI Applications, is featuring its newest REVORAS-based software addition, including coronary plaque analysis (pending FDA ...

Studies Demonstrate xCellSense® Platform's Ability to Predict Clinical Response and Enable Patient Stratification for Drug Development.

Multi-omics is pushing oncology into a new era of clarity. Researchers are moving beyond single markers and now map cancer ...

Lung Cancer Diagnostics Market OverviewThe global lung cancer diagnostics market is undergoing significant expansion as healthcare systems, technology developers, and research institutions intensify ...